REINA: A Phase I Study of Radiation Enhanced IL 12-Necrosis Attraction in Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer Patients
Latest Information Update: 29 Dec 2023
At a glance
- Drugs Bintrafusp alfa (Primary) ; PDS 0301 (Primary)
- Indications Advanced breast cancer; HER2 negative breast cancer; HER2 positive breast cancer; Male breast cancer
- Focus Adverse reactions
- Acronyms REINA
- 31 Aug 2022 Status changed from recruiting to withdrawn prior to enrolment on sponsors request.
- 20 Oct 2021 Planned End Date changed from 15 May 2021 to 15 May 2022.
- 20 Oct 2021 Planned primary completion date changed from 15 May 2021 to 15 May 2022.